Literature DB >> 5666633

Hemodialysis and plasma amino acid composition in chronic renal failure.

P F Gulyassy, J H Peters, S C Lin, P M Ryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5666633     DOI: 10.1093/ajcn/21.6.565

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  8 in total

1.  Cerebral transmitter precursors and metabolites in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

2.  Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids).

Authors:  O P Ganda; T T Aoki; J S Soeldner; R S Morrison; G F Cahill
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

3.  [3-methyl-histidine blood level and renal failure (author's transl)].

Authors:  R Kluthe; R Jontofsohn; N Katz
Journal:  Klin Wochenschr       Date:  1974-04-15

4.  Depletion on dialysis.

Authors: 
Journal:  Br Med J       Date:  1969-06-28

5.  The construction of a panel of serum amino acids for the identification of early chronic kidney disease patients.

Authors:  Rui Li; Jinna Dai; Hui Kang
Journal:  J Clin Lab Anal       Date:  2017-06-23       Impact factor: 2.352

6.  Internal redistribution of tissue protein synthesis in uremia.

Authors:  L Shear
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

7.  Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease.

Authors:  P A Sullivan; D Murnaghan; N Callaghan; B D Kantamaneni; G Curzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-08       Impact factor: 10.154

8.  The role of growth hormone in the glucose intolerance of uremia.

Authors:  R A DeFronzo; J Tobin; G Boden; R Andres
Journal:  Acta Diabetol Lat       Date:  1979 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.